Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso

References

• Cesarman E, Chang Y, Moore PS, et al. Kaposi’s sarcoma-associated herpès virus-like DNA sequences in aids-related body-cavity–based lymphomas”. N Engl J Med. 1995;332(18):1186–1191. doi:10.1056/NEJM199505043321802
   PubMed Web of Science ®Google Scholar
• Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumor virology. Nat Rev Cancer. 2010;10(12):878–889. doi:10.1038/nrc2961
   PubMed Web of Science ®Google Scholar
• Begré L, Rohner E, Mbulaiteye SM, et al. Is human herpès virus 8 infections more common in men than in women? Systematic review and meta-analysis. Int J Cancer. 2016;139(4):776–783. doi:10.1002/ijc.30129
   PubMed Web of Science ®Google Scholar
• Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol. 2017;18(4):529–539. doi:10.1007/s40257-017-0270-4
   PubMed Web of Science ®Google Scholar
• Cavallin LE, Goldschmidt-Clermont P, Mesri EA. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi’s sarcoma associated with HIV/AIDS. PLoS Pathog. 2014;10(7):5–8. doi:10.1371/journal.ppat.1004154
   Web of Science ®Google Scholar
• World Health Organization. Data and statistics of HIV/AIDS. 2020. Available from: https://www.who.int/hiv/data/en/. Accessed July 4, 2022.
   Google Scholar
• Minhas V, Wood C. Epidemiology and transmission of Kaposi’s sarcoma-associated herpès virus. Viruses. 2014;6(11):4178–4194. doi:10.3390/v6114178
   PubMed Web of Science ®Google Scholar
• Stolka K, Ndom P, Hemingway-Foday J, et al. Risk factors for Kaposi’s sarcoma among HIV-positive individuals in a case-control study in Cameroon. Cancer Epidemiol. 2014;38(2):137–143. doi:10.1016/j.canep.2014.02.006
   PubMed Web of Science ®Google Scholar
• Njiki BJ, Ndom P, Mupang L, Agokeng DS. Séroprévalence du virus de l’herpès humain-8 chez des patients VIH positif à l’hôpital général de Yaoundé - Cameroun [Seroprevalence of human herpes virus-8 in HIV-positive patients at the General Hospital of Yaounde - Cameroon]. Pan Afr Med J. 2015;20(69):1–7. French. doi:10.11604/pamj.2015.20.1.5568
   PubMedGoogle Scholar
• Etta EM, Alayande DP, Ramarumo-Mavhandu LG, et al. HHV-8 seroprevalence and genotype distribution in Africa, 1998–2017: a systematic review. Viruses. 2018;10(9):1–17. doi:10.3390/v10090458
   Web of Science ®Google Scholar
• Altuğlu I, Yolcu A, Öcek ZA, et al. Investigation of Human Herpès virus-8 Seroprevalence in Blood Donors and HIV-Positive Patients Admitted to Ege University Medical School Hospital, Turkey”. Mikrobiyoloji Bulteni. 2016;50(1):104–111. doi:10.5578/mb.10751
   PubMed Web of Science ®Google Scholar
• Ilboudo D, Simpore J, Sanou DS, et al. Mother-to-child HIV and HHV-8 transmission in neonates at saint Camille Medical Center in Burkina Faso. Pak J Biol Sci. 2009;12(12):908–913. doi:10.3923/pjbs.2009.908.913
   PubMedGoogle Scholar
• Sagna Y, Koulidiaty J, Diallo I, et al. Profil biologique des patients nouvellement pris en charge pour une infection à VIH à Ouagadougou (Burkina Faso) [Laboratory test features of newly diagnosed adult HIV-Infected patients in Ouagadougou (Burkina Faso)]. Med Sante Trop. 2014;24:307–311. French. doi:10.1684/mst.2014.0381
   PubMedGoogle Scholar
• Karfo R, Kabré E, Coulibaly L, et al. Evolution of biochemical and hematological parameters in patients living with HIV/AIDS treated with antiretroviral therapy at the Aboubacar Sangoulé Lamizana General Camp Medical Center. Pan Afr Med J. 2018;8688:1–7.
   Google Scholar
• Ky-Zerbo O, Desclaux A, El Asmar K, et al. La stigmatisation des PvVIH en Afrique: analyse de ses formes et manifestations au Burkina Faso [Stigmatization of PLWHIV in Africa: analysis of its forms and manifestations in Burkina Faso]. Sante Publique (Paris). 2014;26(3):375–384. French. doi:10.3917/spub.139.0375
   PubMed Web of Science ®Google Scholar
• World Health Organization. HIV country profile: 2017; 2020. Available from: https://www.cfs.hivci.org/country-factsheet.html. Accessed July 4, 2022.
   Google Scholar
• Boileau C, Nguyen V, Sylla M, et al. Low prevalence of detectable HIV plasma viremia in patients treated with antiretroviral therapy in Burkina Faso and Mali. J Acquir Immune Defic Syndr. 2008;48(4):476–484. doi:10.1097/QAI.0b013e31817dc416
   PubMed Web of Science ®Google Scholar
• Kouéta F, Yé D, Zoungrana A, et al. Echecs du traitement antirétroviral de première ligne chez les enfants infectés par le VIH à Ouagadougou (Burkina Faso) [Failure of first-line antiretroviral treatment among HIV-infected children in Ouagadougou, Burkina Faso]. Med Trop. 2010;70(5/6):517–523. French.
   PubMedGoogle Scholar
• World Health Organization. HIV drug resistance; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-drug-resistance. Accessed July 4, 2022.
   Google Scholar
• Touré A, Cissé D, Kadio K, et al. Facteurs associés aux perdus de vue des patients sous traitement antirétroviral dans un centre de traitement ambulatoire du VIH à Conakry, Guinée [Factors associated with dropouts of patients on antiretroviral therapy in an outpatient HIV treatment center in Conakry, Guinea]. Rev Epidemiol Sante Publique. 2018;66(4):273–279. French. doi:10.1016/j.respe.2018.04.057
   Web of Science ®Google Scholar
• Sachithanandham J, Kannangai R, Abraham AM, et al. Human herpes virus-8 infections among subjects with human immunodeficiency virus infection and normal healthy individuals in India. Intervirology. 2013;56:253–257. doi:10.1159/000349890
   PubMed Web of Science ®Google Scholar
• Machado PRL, Farias KJS, Pereira MGM, et al. Human herpès virus 8 (HHV-8) detected by nested polymerase chain reaction (PCR) in HIV patients with or without Kaposi’s sarcoma. An analytic cross-sectional study. Sao Paulo Med J. 2016;134(3):187–192. doi:10.1590/1516-3180.2014.8973010
   Web of Science ®Google Scholar
• Simpore J, Granato M, Santarelli R, et al. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Vir. 2004;31:78–80. doi:10.1016/j.jcv.2004.06.001
   PubMed Web of Science ®Google Scholar
• Ilboudo D, Karou SD, Nadembega WMC, et al. Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the mother-to-child HIV transmission prevention program at Saint Camille. Pak J Biol Sci. 2007;10(17):2831–2837. doi:10.3923/pjbs.2007.2831.2837
   PubMedGoogle Scholar
• Philibert P, Chiche L, Retornaz F, et al. Sarcome de Kaposi associé au VIH: à propos d [HIV-associated Kaposi's sarcoma: a case report illustrating the protective effect of HIV protease inhibitors]. Rev Med Interne. 2017;38:A220–A221. French. doi:10.1016/j.revmed.2017.03.328
   PubMedGoogle Scholar
• Malonga GA, Jary A, Leducq V, et al. Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo. Sci Rep. 2021;11:17442. doi:10.1038/s41598-021-97070-4
   PubMed Web of Science ®Google Scholar
• Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3:31. doi:10.1186/1746-1596-3-31
   PubMed Web of Science ®Google Scholar
• Lamchahab M, Oukkache B, Marouan S, et al. Sarcome de Kaposi compliquant une aplasie médullaire [Kaposi sarcoma complicating bone marrow aplasia]. Pan Afr Med J. 2014;18(169):1–6. French. doi:10.11604/pamj.2014.18.169.1351
   Google Scholar
• Saihi M, Jebali H, Breik N, et al. Le Sarcome de Kaposi iatrogène: à propos de trois observations [Iatrogenic Kaposi's Sarcoma: about three observations]. French. Rev Med Interne. 2018;39(1):A199. doi:10.1016/j.revmed.2018.03.169
   Google Scholar
• El Jouari O, Chaymae J, Senhaji G, et al. Iatrogenic Kaposi sarcoma in an immune competent woman. Int J Cutaneous Disord Med Case. 2018;1(1):1–4.
   Google Scholar